Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 1
2013 1
2015 2
2016 1
2017 1
2018 2
2019 1
2020 3
2021 3
2022 6
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study.
Faghri F, Brunn F, Dadu A; PARALS consortium; ERRALS consortium; Zucchi E, Martinelli I, Mazzini L, Vasta R, Canosa A, Moglia C, Calvo A, Nalls MA, Campbell RH, Mandrioli J, Traynor BJ, Chiò A. Faghri F, et al. Lancet Digit Health. 2022 May;4(5):e359-e369. doi: 10.1016/S2589-7500(21)00274-0. Epub 2022 Mar 24. Lancet Digit Health. 2022. PMID: 35341712 Free PMC article.
Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study.
Zucchi E, Musazzi UM, Fedele G, Martinelli I, Gianferrari G, Simonini C, Fini N, Ghezzi A, Caputo M, Sette E, Vacchiano V, Zinno L, Anceschi P, Canali E, Vinceti M, Ferro S, Mandrioli J; ERRALS study group. Zucchi E, et al. EClinicalMedicine. 2023 Oct 5;65:102256. doi: 10.1016/j.eclinm.2023.102256. eCollection 2023 Nov. EClinicalMedicine. 2023. PMID: 37842553 Free PMC article.
Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson's disease patients.
Zago E, Dal Molin A, Dimitri GM, Xumerle L, Pirazzini C, Bacalini MG, Maturo MG, Azevedo T, Spasov S, Gómez-Garre P, Periñán MT, Jesús S, Baldelli L, Sambati L, Calandra-Buonaura G, Garagnani P, Provini F, Cortelli P, Mir P, Trenkwalder C, Mollenhauer B, Franceschi C, Liò P, Nardini C; PROPAG-AGEING Consortium. Zago E, et al. Sci Rep. 2022 Jan 25;12(1):1330. doi: 10.1038/s41598-022-05227-6. Sci Rep. 2022. PMID: 35079043 Free PMC article.
A geroscience approach for Parkinson's disease: Conceptual framework and design of PROPAG-AGEING project.
Pirazzini C, Azevedo T, Baldelli L, Bartoletti-Stella A, Calandra-Buonaura G, Dal Molin A, Dimitri GM, Doykov I, Gómez-Garre P, Hägg S, Hällqvist J, Halsband C, Heywood W, Jesús S, Jylhävä J, Kwiatkowska KM, Labrador-Espinosa MA, Licari C, Maturo MG, Mengozzi G, Meoni G, Milazzo M, Periñán-Tocino MT, Ravaioli F, Sala C, Sambati L, Schade S, Schreglmann S, Spasov S, Tenori L, Williams D, Xumerle L, Zago E, Bhatia KP, Capellari S, Cortelli P, Garagnani P, Houlden H, Liò P, Luchinat C, Delledonne M, Mills K, Mir P, Mollenhauer B, Nardini C, Pedersen NL, Provini F, Strom S, Trenkwalder C, Turano P, Bacalini MG, Franceschi C; PROPAG-AGEING Consortium. Pirazzini C, et al. Mech Ageing Dev. 2021 Mar;194:111426. doi: 10.1016/j.mad.2020.111426. Epub 2020 Dec 29. Mech Ageing Dev. 2021. PMID: 33385396 Free article.
Riluzole and other prognostic factors in ALS: a population-based registry study in Italy.
Mandrioli J, Malerba SA, Beghi E, Fini N, Fasano A, Zucchi E, De Pasqua S, Guidi C, Terlizzi E, Sette E, Ravasio A, Casmiro M, Salvi F, Liguori R, Zinno L, Handouk Y, Rizzi R, Borghi A, Rinaldi R, Medici D, Santangelo M, Granieri E, Mussuto V, Aiello M, Ferro S, Vinceti M; ERRALS Group. Mandrioli J, et al. J Neurol. 2018 Apr;265(4):817-827. doi: 10.1007/s00415-018-8778-y. Epub 2018 Feb 5. J Neurol. 2018. PMID: 29404735
Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression.
Tavazzi E, Daberdaku S, Zandonà A, Vasta R, Nefussy B, Lunetta C, Mora G, Mandrioli J, Grisan E, Tarlarini C, Calvo A, Moglia C, Drory V, Gotkine M, Chiò A, Di Camillo B; Piemonte, Valle d’Aosta Register for ALS (PARALS), for the Emilia Romagna Registry for ALS (ERRALS). Tavazzi E, et al. J Neurol. 2022 Jul;269(7):3858-3878. doi: 10.1007/s00415-022-11022-0. Epub 2022 Mar 10. J Neurol. 2022. PMID: 35266043 Free PMC article.
Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients.
Baldelli L, Schade S, Jesús S, Schreglmann SR, Sambati L, Gómez-Garre P, Halsband C, Calandra-Buonaura G, Adarmes-Gómez AD, Sixel-Döring F, Zenesini C, Pirazzini C, Garagnani P, Bacalini MG, Bhatia KP, Cortelli P, Mollenhauer B, Franceschi C; PROPAG-AGEING consortium; Mir P, Trenkwalder C, Provini F. Baldelli L, et al. NPJ Parkinsons Dis. 2021 Sep 7;7(1):78. doi: 10.1038/s41531-021-00219-1. NPJ Parkinsons Dis. 2021. PMID: 34493736 Free PMC article.
Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy.
Mandrioli J, Biguzzi S, Guidi C, Sette E, Terlizzi E, Ravasio A, Casmiro M, Salvi F, Liguori R, Rizzi R, Pietrini V, Borghi A, Rinaldi R, Fini N, Chierici E, Santangelo M, Granieri E, Mussuto V, De Pasqua S, Georgoulopoulou E, Fasano A; ERRALS Group; Ferro S, D'Alessandro R. Mandrioli J, et al. Neurol Sci. 2015 Dec;36(12):2243-52. doi: 10.1007/s10072-015-2343-6. Epub 2015 Jul 24. Neurol Sci. 2015. PMID: 26205535
21 results